11/06/2018

United Healthcare Update

Update on Injection and Infusion Services Policy

Update on Injection and Infusion Services Policy

In the September Network Bulletin, an update to the Injection and Infusion Services Policy was announced. The change involved a CPT® coding requirement that allowed only therapeutic infusion codes (96365 and 96366) to be reimbursed when reported with (J3380) Vedolizumab/Entyvio, (J0129) Abatacept/Orencia, (J3262) Tocilizumab/Actemra and/or (J1602) Golimumab/Simponi instead of chemotherapy infusion codes (96413 and 96415). This planned change to the policy is undergoing additional evaluation. The change will not be effective on Dec. 1, 2018 as previously announced.